Management expansion strengthens capabilities in developing new class of alpha radioligand therapies CAMBRIDGE, Mass. and OSLO, Norway and LONDON and BASEL, Switzerland, Oct. 5, 2023 /PRNewswire/ — ARTBIO, Inc. (ARTBIO), a clinical-stage radiopharmaceutical company developing a new class…